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recent non-invasive approach to measure PWV is by using 
cardiovascular magnetic resonance imaging (CMR). CMR-
derived PWV is more reliable, not limited by imaging planes, 
and CMR offers more possibilities regarding cardiovascular 
imaging (i.e. aortic anatomy, plaque visualisation and char-
acterisation, cardiac function, carotid patency). Specifically 
regarding PWV, CMR also allows measurement of regional 
PWV in addition to global PWV, which will be discussed 
later. Moreover, CMR is increasingly implemented in rou-
tine clinical care and becoming more widely available.
Through-plane velocity-encoded CMR at two (or more) 
sites perpendicular to the aorta is the most commonly used 
CMR technique for PWV assessment. The accuracy and 
reliability of CMR-based PWV assessment depends on 
temporal resolution, spatial sampling density and accurate 
ECG gating. There are several post-processing methods, but 
currently the time-to-foot method is used most often. After 
reconstruction of the waveform at each acquisition plane, 
the temporal shift (or transit time) between the waveforms is 
assessed using the foot of the waveforms: the intersection of 
a line fitted to the waveform upslope (through data points at 
20 and 80 % of maximum velocity) with the horizontal axis 
or base velocity. Alternatively, the cross-correlation method 
has been suggested [1]; however, there is no consensus yet 
regarding a method of preference.
In 2010, Westenberg et al. [2] validated two-directional 
in-plane velocity-encoded CMR and showed better cor-
relation with the gold standard and better reproducibility 
than ‘traditional’ through-plane velocity-encoded CMR. 
With this technique flow velocity is assessed lengthwise in 
the aorta (from the candy cane view) as opposed to cross-
sectionally in the through-plane method. From the acquired 
images cross-sectional planes along the aortic centreline are 
defined, producing 200 waveforms from which PWV can 
be derived. By segmenting the aorta in a standardised fash-
Pulse wave velocity (PWV) has emerged as a marker for 
arterial stiffness with a promising future role in cardiovas-
cular risk stratification. The pressure wave produced by sys-
tolic pumping of the heart travels along the aorta and other 
vasculature throughout the body. With deterioration of the 
vessel wall, whether due to age, connective tissue disease 
or atherosclerosis, the transit time of the pulse wave from 
point A to B becomes shorter, meaning that PWV is directly 
related to the mechanical properties of the vessel. Cardio-
vascular disease leading to aortic dilatation typically occurs 
through a gradual process, although the clinical manifesta-
tion can be acute. Feared complications of aortic dilatation 
are dissection and rupture, with a high risk for mortality 
and morbidity. Indication for preventive surgical interven-
tion is currently mostly based on aortic diameter. An added 
measure for detection of subclinical aortic disease is desir-
able for more tailored risk stratification to guide preventive 
intervention.
Several methods are available for measuring PWV, all 
based on the general principle PWV = ∆d/∆t where ∆d is 
the distance between two planes and ∆t is the temporal shift 
between two waveforms. Intravascular pressure or flow-
derived PWV is the gold standard method, but unattractive 
for general implementation due to its invasive nature. Non-
invasive methods include vascular applanation tonometry or 
Doppler ultrasound over the carotid and femoral artery (i.e. 
external measurement of pressure or flow velocity respec-
tively). Their main pitfall is inaccuracy due to erroneous 
distance measurement, especially in obese patients. A more 
R. Nijveldt () · R.P. Amier
Department of Cardiology, VU University Medical Center,
Amsterdam, the Netherlands
e-mail: r.nijveldt@cardiologie-vumc.nl
492 Neth Heart J (2015) 23:491–492
ion, regional PWV values can be determined. Local PWV 
assessment is possible as well, but accuracy depends on the 
temporal resolution. The in-plane CMR technique is more 
time consuming due to increased scanning time and more 
intensive image processing, but its unique strength lies in 
the ability to determine regional and local PWV. Theoreti-
cally, regional aortic stiffness assessment might allow early 
detection of disease, whereas global PWV can still be nor-
mal if the aorta is only affected regionally.
The predictive value of PWV has been assessed in a sub-
study of the Dallas Heart Study in 2122 healthy subjects 
with an 8-year follow-up period [3]. The study showed 
CMR-derived PWV to be associated with the occurrence of 
cardiovascular events and improved risk stratification when 
added to the Framingham Risk Score. In the general popu-
lation PWV seems potentially useful in trials regarding ath-
erosclerosis, however, it may have more clinical potential 
in patients at risk for progression of aortic disease. In 2013 
Kröner et al. [4] investigated regional PWV as a predictor 
for aortic dilatation over time in patients with Marfan syn-
drome using the in-plane velocity-encoded MR technique. 
They confirmed previous data by showing higher PWV in 
Marfan patients compared with healthy control subjects, 
and a moderate to high specificity for regional PWV as a 
predictor for aortic diameter growth. In the current issue of 
the NHJ, Kröner et al. [5] studied the relation of regional 
PWV and aortic diameter in patients with thoracic aortic 
aneurysm, using in-plane velocity-encoded CMR, and show 
promising results. They demonstrated high specificity in 
the descending thoracic and abdominal aorta and moderate 
specificity for the ascending aorta and aortic arch. On the 
other hand, sensitivity was surprisingly low. The results of 
the study are mostly driven by the small number of patients 
and low prevalence of the outcome measure (i.e. abnormal 
diameter). Regardless, normal PWV seems to successfully 
identify absence of disease, which in itself is also useful. It 
is unknown how PWV performs in patient groups with more 
extensive disease, and additionally how PWV will eventu-
ally monitor patients with aortic disease and indicate timing 
of surgical intervention.
Concluding, PWV as assessed by CMR is reliable, fea-
sible and has high potential as an arterial stiffness marker. 
Small studies in patients at risk for (further) aortic dilatation 
show normal PWV to indicate absence of increased aortic 
diameter, which might improve cardiovascular risk stratifi-
cation. Clinical implementation will depend on the predic-
tive value of PWV in further studies with specific at-risk 
patient populations, larger cohorts, longer follow-up and 
monitoring of clinical events. Ideally, if PWV improves our 
current risk stratification, high-risk patients can be referred 
for surgical intervention timely, and low-risk patients can be 
deferred safely.
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